Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2020-15809
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
spxmanage on certain SpinetiX devices allows requests that access unintended resources because of SSRF and Path Traversal. This affects HMP350, HMP300, and DiVA through 4.5.2-1.0.36229; HMP400 and HMP400W through 4.5.2-1.0.2-1eb2ffbd; and DSOS through 4.5.2-1.0.2-1eb2ffbd.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
SpinetiX SpinetiX 路径遍历漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
SpinetiX是德国SpinetiX公司的一个应用平台。提供解决方案套件。 SpinetiX devices 存在安全漏洞,该漏洞源于SSRF和路径遍历而访问非预期资源的请求。以下产品及版本受到影响:HMP350, HMP300, and DiVA through 4.5.2-1.0.36229; HMP400 and HMP400W through 4.5.2-1.0.2-1eb2ffbd; and DSOS through 4.5.2-1.0.2-1eb2ffbd。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2020-15809
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2020-15809
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2020-15809

No comments yet


Leave a comment